- This infographic provides an overview of the epidemiology of reported hepatitis C cases in 2021 in Canada.
- An analysis of prescription data in nine Canadian provinces, 2019-2022
- WebinarThis second webinar in a series on syphilis in Canada will investigate how these alarming developments can occur at a time when highly effective tools are available to prevent and treat both HIV and…
- Major change is coming – long-acting HIV pre-exposure prophylaxis
- Safety and effectiveness of long-acting cabotegravir for prevention in men and transgender women
- Safety and effectiveness of long-acting cabotegravir for prevention in cisgender women
- Long-acting cabotegravir - focus on transgender women
- In context – long-acting cabotegravir for HIV prevention
- Learning from a case of breakthrough infection with long-acting cabotegravir for prevention